Healthy Extracts New Clinic – GuruFocus.com

LAS VEGAS, June 08, 2022 (GLOBE NEWSWIRE) — Healthy Extracts Inc. (HYEX), a leading innovator of clinically proven herbal products for heart and brain health, announced a poster presentation at the American College of Sports Medicine’s 2022 CMHA Annual Meeting in San Diego, California.

Neil Wolkodoff, PhD, Medical Program Director, Colorado Center for Health and Sports Science, co-authored and presented a poster titled “Effects of a Phytonutrient Complex on Migraine: Comparing Overall Episodes to Quality of Life Factors” . The poster highlights the improved quality of life (QOL) of migraine sufferers after consuming Healthy Extracts’ headache formulation, UBN RELIEF™.

The study concluded that Healthy Extracts’ RELIEF, a medium-chain triglyceride nootropic formulation, provided significant reductions in the number and duration of migraine episodes in people with chronic migraine. 30 migraine sufferers in the intervention group consumed the RELIEF formulation every morning for 60 days, while 10 subjects were placed in a control group and received a placebo.

The number of migraine episodes for the intervention group decreased significantly by 53%, from 11.6 to 5.4 per 30 days. The average episode length also decreased, from 260 minutes to 158 minutes. These results were associated with a 43% improvement in self-rated quality of life.

“This presentation demonstrates the importance of educating consumers about the unique benefits of Healthy Extracts’ proprietary RELIEF formulation,” said Dr. Gerald M. Haase, Poster Co-Author, Healthy Extracts Advisor and Clinical Professor. of surgery at the University of Colorado Medical School and Colorado Children’s Hospital.

“These strong results demonstrated the ability of UBN RELIEF to relieve symptoms associated with migraines and improve quality of life when taken daily for 60 days,” he continued. “Additionally, the study findings reveal that UBN RELIEF may be a natural remedy adjunct option for the tens of millions of migraine sufferers. Healthcare providers and consumers can expect this natural formulation to offer a significant advantage.

The poster was also co-authored by Dr. Reginald W. Kapteyn, a physical medicine and rehabilitation specialist with Orthopedic Associates of Muskegon in Michigan.

The study further builds on results recently reported by Healthy Extracts of a prospective, randomized, double-blind, placebo-controlled clinical trial that evaluated UBN RELIEF. The results were published in January in the World Journal of Advanced Research and Reviews.

The trial concluded that taking a single daily serving of UBN RELIEF for 60 days can naturally reduce or improve symptoms associated with migraines, as well as improve cognitive function, sleep satisfaction and overall quality of life. .

The results were highly significant considering that about one in six Americans, or about 55 million people, suffer from migraines and severe headaches, according to government health studies. Migraines are among the top reasons for emergency room visits, and a high percentage of migraine episodes result in temporary and long-term disability. This results in loss of time for employment, education, housework, hobbies and other important daily activities.

“These published, peer-reviewed clinical research studies strongly differentiate our products in the marketplace and assure our customers that they will see results,” said Duke Pitts, president of Healthy Extracts. “It is important to note that these positive results from UBN RELIEF were achieved without producing any undesirable side effects.”

UBN RELIEF is based on a specialized version of an exclusive, patent-protected formulation from Healthy Extracts. The unique formulation is the result of over 20 years of scientific research, including multiple clinical studies on key ingredients. The ingredients are of natural origin and contain no caffeine or added sugar.

In addition to severe discomfort and distress, clinical studies have shown that migraines are also linked to poor cognitive performance. The key ingredients in UBN RELIEF have been clinically demonstrated improve human cognitive behavior and mental focus by improving the functioning of brain areas responsible for attention, memory, mood and reaction times by up to 46%.

The new trial results provide additional scientific support for Healthy Extracts’ patent-protected formulations, and the company has filed an application with the FDA for approval of a qualified health claim regarding clinical benefits in migraine headaches. .

Healthy Extracts’ research and product development focuses on the brain health supplement market which is expected grow at a compound annual growth rate (CAGR) of 8% to reach $15.7 billion by 2030.

To learn more about other RELIEF and Healthy Extracts products, visit tryubn.com/relief and bergametna.com.

About UBN RELIEF
UBN RELIEF is based on a specialized version of an exclusive, patent-protected formulation from Healthy Extracts. The special formulation is the result of over 20 years of scientific research, including multiple clinical studies on key ingredients. The ingredients are of natural origin and contain no caffeine or added sugar.

Whether as a scoop added to water or coffee, or mixed into a smoothie, the powerful brain-activating benefits of RELIEF have been shown to last eight hours or more. The company plans to soon offer RELIEF as a single-serving, biodegradable gel pack that can be easily consumed anytime, anywhere, with no liquids or mixing required.

The company’s proprietary formulation is protected by several issued and pending patents. The formulation includes specific, highly concentrated Medium Chain Triglycerides (MCTs), which are derived from Healthy Extracts’ patent-pending extraction process. MCTs have been shown to elevate the level of ketones in the brain.

The formulation also contains a proprietary blend of other key ingredients, including a naturally sourced nootropic spearmint extract that is clinically shown to support mental focus during the day without disrupting sleep at night; a protective antioxidant found naturally in the body that helps the brain function optimally and promotes better mood and sleep patterns; and a unique natural marigold extract that is scientifically proven to block blue light, improve brain carotenoid antioxidant levels, and replenish lutein, which is essential for optimal eye health.

Learn more about UBN RELIEF or order today at tryubn.com.

About Healthy Extracts “Relive the Young Life”
Healthy Extracts Inc. is a platform for the development or acquisition of scientifically and clinically proven proprietary herbal products in select high growth categories within the multi-billion dollar nutraceutical market.

The Company’s subsidiaries, BergametNA™ and Ultimate Brain Nutrients™ (UBN), offer natural nutraceutical supplements for heart and brain health. This includes the only heart health supplement containing Citrus Bergamot SuperFruit™. This superfruit is known to have the highest quality and concentration of polyphenols and flavonoids, and with heart-healthy benefits backed by over 17 clinical studies.

UBN KETONOMICS® proprietary formulations have been clinically shown to improve brain health, including memory, cognition, focus and neuro-energy. UBN seeks IP licensing opportunities to monetize its IP portfolio consisting of several issued and pending patents.

For more information visit: healthyextractsinc.com, bergametna.com Where tryubn.com.

Forward-Looking Statements and Safe Harbor Notices

All statements other than statements of historical facts included in this press release are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). These forward-looking statements include our expectations and statements that use forward-looking terms such as “projected”, “expect”, “possibility” and “anticipate”. The realization or success of the matters covered by these forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the company’s annual report on Form 10-K filed with the SEC on February 19, 2021 and future periodic reports filed with the SEC. All of the Company’s forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.

The Company cautions that the statements and assumptions made in this press release constitute forward-looking statements and are not guarantees of future performance. Forward-looking statements are based on management’s estimates and opinions at the time the statements are made. The information presented here is valid only as of the date hereof. The Company and its management assume no obligation to revise these statements after the date of this press release.

Food and Drug Administration Disclosure

The product and formulation shown in this release is not intended for use or sale to persons under the age of 12. This product should be used only as directed on the label. Consult a physician before use if you have a serious medical condition or are using prescription medication. A doctor’s advice should be sought before using this product and any dietary supplement. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.

BergametNA™, Ultimate Brain Nutrients™, UBN™, Citrus Bergamot SuperFruit™ and F4T® are registered trademarks of Healthy Extracts Inc.™

Healthy Extracts Company Contact
Duke Pitts, President
Healthy Extracts Inc.
Tel (720) 463-1004
E-mail address

Contact with investors and the media
Ronald Both or Justin Lumley
CMA Investor and Media Relations
Tel (949) 432-7566
E-mail address

Media Contact:
Tim Randall
CMA
Tel (949) 432-7572
Contact us by email

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d10c20ac-ef35-41df-adbe-d1dda75c521b

Healthy-Extracts-Inc-.png

About Terry Gongora

Check Also

CDC report on ‘superbugs’, FDA clears Novavax

Federal officials urged — practically begged — eligible Americans to stay up to date with …